Yan-qiao Zhang
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The antibody-drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial.
Journal: Nature medicine
Published: January 22, 2025
Claudin 18.2-targeting antibody-drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial.
Journal: The Lancet. Oncology
Published: August 14, 2024
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023.
Journal: Cancer communications (London, England)
Published: December 08, 2023
Phase 1 multicenter, dose-expansion study of ARX788 as monotherapy in HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma.
Journal: Cell reports. Medicine
Published: July 16, 2022
Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial.
Journal: BMC medicine
Published: June 09, 2022
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 12, 2022
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021.
Journal: Cancer communications (London, England)
Published: June 05, 2021
The Impact of Mismatch Repair Status on Prognosis of Patients With Gastric Cancer: A Multicenter Analysis.
Journal: Frontiers in oncology
Published: May 21, 2021
Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer.
Journal: Cancer research and treatment
Published: April 18, 2020
A Hopeful Natural Product, Pristimerin, Induces Apoptosis, Cell Cycle Arrest, and Autophagy in Esophageal Cancer Cells.
Journal: Analytical cellular pathology (Amsterdam)
Published: December 09, 2018
The functional role of long non-coding RNA in digestive system carcinomas.
Journal: Bulletin du cancer
Published: October 09, 2014
Last Updated: 09/26/2026